Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
0.80 Down 0.00(0.01%) May 27, 3:24PM EDT
Prev Close:0.80
Open:0.80
Bid:0.78 x 500
Ask:0.80 x 100
1y Target Est:1.50
Beta:2.67965
Next Earnings Date:N/A
Day's Range:0.75 - 0.80
52wk Range:0.70 - 9.30
Volume:9,585
Avg Vol (3m):51,900
Market Cap:31.10M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-0.33
Quarterly EPS Est (Sep-15) :N/A
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback